Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 9, 1998, Pages 849-855

  Delvaux, M ^a,c   Louvel, D ^a   Mamet, J P ^b   Campos Oriola, R ^b   Frexinos, J ^a  

^a Gastroenterology Unit   (France)

^b Glaxo Laboratories   (France)

^c CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON DILATATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IRRITABLE COLON; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CARBOLINES; COLON; COLONIC DISEASES, FUNCTIONAL; COMPLIANCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN THRESHOLD; PELVIC PAIN; PERCEPTION; SEROTONIN ANTAGONISTS;

EID: 0031658491     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00375.x     Document Type: Article

References (33)

1. Buéno L, Fioramonti J, Rukebusch Y, Frexinos J, Coulon P. Evaluation of colonic myoelectric activity in health and in functional disorders. Gut 1985; 21: 480-5.
2. Frexinos J, Fioramonti J, Buéno L. Colonic myoelectrical activity in IBS painless diarrhoea. Gut 1987; 28: 1613-18.
3. Whitehead WE, Engle BJ, Schuster MM. Irritable bowel syndrome: physiological and psychological difference between diarrhoea-predominant and constipation-predominant patients. Dig Dig Sci 1980; 55: 404-13.
4. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in the irritable bowel syndrome. Gastroenterology 1988; 14: 1150-6.
5. Camilleri M, Neri M. Motility disorders and stress. Dig Dis Sci 1989; 54: 1777-86.
6. Sullivan MA, Cohen S, Snape WJ Jr. Colonic myoelectrical activity in irritable bowel syndrome. Effect of eating and anticholinergics. N Engl J Med 1978; 298: 878-83.
7. Bazzochi G, Ellis J, Villanueva-Meyer J, et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology 1990; 98: 686-95.
8. Snape WJ Jr. Irritable bowel syndrome. In: Cohen S, Soloway RD, eds. Functional Disorders of the Gastrointestinal Tract. New York: Churchill Livingstone, 1987: 69-85.
9. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1975; 14: 125-32.
10. Swarbrick ET, Bat L, Hegorty JE, Williams CB. Site of pain from the irritable bowel. Lancet 1980; ii: 443-6.
11. Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distension in irritable bowel syndrome. Gastroenterology 1990; 98: 1187-92.
12. Ritchie J. Mechanisms of pain in irritable bowel syndrome. In: Read, NW, ed. Irritable Bowel Syndrome. Philadelphia: Grune and Stratton, 1985: 165-172.
13. Dawson AM. Origin of pain in the irritable bowel syndrome. In: Read, NW, ed. Irritable Bowel Syndrome. Philadelphia: Grune and Stratton, 1985: 155-162.
14. Bradette M, Delvaux M, Staumont G, Fioramonti J, Buéno L, Frexinos J. Evaluation of colonic sensory thresholds in IBS patients using a barostat: definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci 1994; 39: 449-57.
15. Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975; 295: 524-6.
16. Mayer EA, Gebhart GF. Functional bowel disorders and the visceral hyperalgesia hypothesis. In: Mayer EA, Raybould HE, eds. Basic and Clinical Aspects of Chronic Abdominal Pain. New York: Elsevier, 1993: 3-28.
17. Camilleri M, von der Ohe MR. Drugs affecting serotonin receptors. Bailliére's Clin Gastroenterol 1994; 8: 301-19.
18. Prior A, Read NW. Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5-HT3 receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175-80.
19. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5-HT3 antagonist (ondansetron) on rectal contractility and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 543-51.
20. Goldberg PA, Kamm MA, Setti-Carraro P, et al. 5-HT3 antagonism does not modify visceral sensation or compliance in healthy subjects. Gastroenterology 1993; 104: A512 (Abstract).
21. Clayton NM, Gale JD, Bountra C, Forster ER. Normalisation of perturbed small bowel transit by alosetron, a 5-HT3 receptor antagonist in the rat. Dig Dis Sci 1996; 41: 1903 (A95).
22. Scott CM, Green A, Gale JD, Bunce KT. The effect of 5-HT3 receptor antagonists on the depressor effect of colorectal distension in the anaesthetised rat. Br J Pharmacol 1994; 112: 101P.
23. Bardhan K, Bodemar G, Geldof H, Schutz E, Snell C, Darekar B. A double-blind placebo-controlled study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome. Gastroenterology 1996; 110: A630 (Abstract).
24. Thompson WS, Dotterval G, Drossman DA, Heaton KW, Kruis SW. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92-5.
25. Hatchet T, Caussette M. A multifunction and programmable computerised barostat. Gastroenterol Clin Biol 1993; 17: 547-51.
26. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
27. Delvaux M, Louvel D, Scherre B, Fraitag B, Frexinos J. The k-agonist Fedotozine increases thresholds of first sensation and pain perception to colonic distension in patients with Irritable Bowel Syndrome. Gastroenterology 1995; 108: A590 (Abstract).
28. von der Ohe MR, Camilleri M, Kvols LK. A 5-HT3 antagonist corrects the post-prandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 1994; 106: 1184-9.
29. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of post-prandial colonic tonic and phasic responses in man. Gut 1994; 35: 536-41.
30. Lagier E, Delvaux M, Mètivier S, et al. Colonic tone influences thresholds of sensory perception to luminal distension in IBS patients. Gastroenterology 1996; 110: A700 (Abstract).
31. Distrutti E, Azpiroz F, Soldevilla A, Malagelada JR. Perception of rectal distension depends on wall tension, but not on expansion. Gastroenterology 1996; 110: A657 (Abstract).
32. Banner SE, Sanger GJ. The effect of 5HT3 receptor antagonists on visceral pseudoaffective reflexes. Paper presented at Serotonin 1991. 5-hydroxytryptamine-CNS receptors and brain function. Birmingham UK, 1991; 78 (Abstract).
33. Morteau O, Eeckhout C, Buéno L. Effect of the 5-HT3 antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats. Fundam Clin Pharmacol 1994; 8: 553-62.